Logo image of IBOC

INTERNATIONAL BANCSHARES CRP (IBOC) Stock Fundamental Analysis

NASDAQ:IBOC - Nasdaq - US4590441030 - Common Stock - Currency: USD

63.13  +0.36 (+0.57%)

Fundamental Rating

4

Taking everything into account, IBOC scores 4 out of 10 in our fundamental rating. IBOC was compared to 397 industry peers in the Banks industry. While IBOC is still in line with the averages on profitability rating, there are concerns on its financial health. IBOC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

IBOC had positive earnings in the past year.
IBOC had a positive operating cash flow in the past year.
IBOC had positive earnings in each of the past 5 years.
Each year in the past 5 years IBOC had a positive operating cash flow.
IBOC Yearly Net Income VS EBIT VS OCF VS FCFIBOC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

IBOC has a Return On Assets of 2.60%. This is amongst the best in the industry. IBOC outperforms 98.49% of its industry peers.
IBOC has a better Return On Equity (14.63%) than 90.93% of its industry peers.
Industry RankSector Rank
ROA 2.6%
ROE 14.63%
ROIC N/A
ROA(3y)2.42%
ROA(5y)2.01%
ROE(3y)15.38%
ROE(5y)12.96%
ROIC(3y)N/A
ROIC(5y)N/A
IBOC Yearly ROA, ROE, ROICIBOC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

IBOC has a Profit Margin of 49.08%. This is amongst the best in the industry. IBOC outperforms 100.00% of its industry peers.
IBOC's Profit Margin has improved in the last couple of years.
IBOC does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 49.08%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.69%
PM growth 5Y7.09%
GM growth 3YN/A
GM growth 5YN/A
IBOC Yearly Profit, Operating, Gross MarginsIBOC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

3

2. Health

2.1 Basic Checks

IBOC does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, IBOC has more shares outstanding
The number of shares outstanding for IBOC has been reduced compared to 5 years ago.
Compared to 1 year ago, IBOC has an improved debt to assets ratio.
IBOC Yearly Shares OutstandingIBOC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IBOC Yearly Total Debt VS Total AssetsIBOC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

The Debt to FCF ratio of IBOC is 1.40, which is an excellent value as it means it would take IBOC, only 1.40 years of fcf income to pay off all of its debts.
IBOC has a Debt to FCF ratio of 1.40. This is in the better half of the industry: IBOC outperforms 64.74% of its industry peers.
A Debt/Equity ratio of 0.23 indicates that IBOC is not too dependend on debt financing.
The Debt to Equity ratio of IBOC (0.23) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.4
Altman-Z N/A
ROIC/WACCN/A
WACC11.21%
IBOC Yearly LT Debt VS Equity VS FCFIBOC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
IBOC Yearly Current Assets VS Current LiabilitesIBOC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

2

3. Growth

3.1 Past

The earnings per share for IBOC have decreased by -0.64% in the last year.
Measured over the past years, IBOC shows a quite strong growth in Earnings Per Share. The EPS has been growing by 16.05% on average per year.
The Revenue has been growing slightly by 0.01% in the past year.
The Revenue has been growing slightly by 7.21% on average over the past years.
EPS 1Y (TTM)-0.64%
EPS 3Y17.97%
EPS 5Y16.05%
EPS Q2Q%7.98%
Revenue 1Y (TTM)0.01%
Revenue growth 3Y11.99%
Revenue growth 5Y7.21%
Sales Q2Q%-1.31%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
IBOC Yearly Revenue VS EstimatesIBOC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 9.61, which indicates a very decent valuation of IBOC.
Based on the Price/Earnings ratio, IBOC is valued cheaper than 80.60% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.18, IBOC is valued rather cheaply.
Industry RankSector Rank
PE 9.61
Fwd PE N/A
IBOC Price Earnings VS Forward Price EarningsIBOC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

75.31% of the companies in the same industry are more expensive than IBOC, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.54
EV/EBITDA N/A
IBOC Per share dataIBOC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.6
EPS Next 2YN/A
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

IBOC has a Yearly Dividend Yield of 2.23%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 3.50, IBOC is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.45, IBOC has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.23%

5.2 History

The dividend of IBOC has a limited annual growth rate of 4.72%.
IBOC has paid a dividend for at least 10 years, which is a reliable track record.
IBOC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.72%
Div Incr Years15
Div Non Decr Years15
IBOC Yearly Dividends per shareIBOC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

20.06% of the earnings are spent on dividend by IBOC. This is a low number and sustainable payout ratio.
IBOC's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP20.06%
EPS Next 2YN/A
EPS Next 3YN/A
IBOC Yearly Income VS Free CF VS DividendIBOC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
IBOC Dividend Payout.IBOC Dividend Payout, showing the Payout Ratio.IBOC Dividend Payout.PayoutRetained Earnings

INTERNATIONAL BANCSHARES CRP

NASDAQ:IBOC (5/5/2025, 10:58:57 AM)

63.13

+0.36 (+0.57%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)05-01 2025-05-01
Earnings (Next)07-30 2025-07-30
Inst Owners69.24%
Inst Owner Change-0.1%
Ins Owners13.9%
Ins Owner Change-0.32%
Market Cap3.93B
Analysts0
Price TargetN/A
Short Float %2.03%
Short Ratio3.24
Dividend
Industry RankSector Rank
Dividend Yield 2.23%
Yearly Dividend1.32
Dividend Growth(5Y)4.72%
DP20.06%
Div Incr Years15
Div Non Decr Years15
Ex-Date02-14 2025-02-14 (0.7)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 9.61
Fwd PE N/A
P/S 4.71
P/FCF 8.54
P/OCF 8.29
P/B 1.4
P/tB 1.56
EV/EBITDA N/A
EPS(TTM)6.57
EY10.41%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)7.39
FCFY11.71%
OCF(TTM)7.62
OCFY12.07%
SpS13.4
BVpS44.95
TBVpS40.41
PEG (NY)N/A
PEG (5Y)0.6
Profitability
Industry RankSector Rank
ROA 2.6%
ROE 14.63%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 49.08%
GM N/A
FCFM 55.16%
ROA(3y)2.42%
ROA(5y)2.01%
ROE(3y)15.38%
ROE(5y)12.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y4.69%
PM growth 5Y7.09%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF 1.4
Debt/EBITDA N/A
Cap/Depr 62.81%
Cap/Sales 1.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 112.38%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score6
WACC11.21%
ROIC/WACCN/A
Cap/Depr(3y)92.06%
Cap/Depr(5y)68.29%
Cap/Sales(3y)2.61%
Cap/Sales(5y)2.17%
Profit Quality(3y)114.58%
Profit Quality(5y)126.58%
High Growth Momentum
Growth
EPS 1Y (TTM)-0.64%
EPS 3Y17.97%
EPS 5Y16.05%
EPS Q2Q%7.98%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.01%
Revenue growth 3Y11.99%
Revenue growth 5Y7.21%
Sales Q2Q%-1.31%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y2.88%
FCF growth 3Y17.8%
FCF growth 5Y10.27%
OCF growth 1Y-0.1%
OCF growth 3Y17.56%
OCF growth 5Y8.75%